GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (STU:L1PA) » Definitions » PB Ratio

Lee's Pharmaceutical Holdings (STU:L1PA) PB Ratio : 0.48 (As of Apr. 01, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Lee's Pharmaceutical Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-01), Lee's Pharmaceutical Holdings's share price is €0.166. Lee's Pharmaceutical Holdings's Book Value per Share for the quarter that ended in Jun. 2024 was €0.35. Hence, Lee's Pharmaceutical Holdings's PB Ratio of today is 0.48.

Warning Sign:

Lee's Pharmaceutical Holdings Ltd stock PB Ratio (=0.53) is close to 2-year high of 0.53.

The historical rank and industry rank for Lee's Pharmaceutical Holdings's PB Ratio or its related term are showing as below:

STU:L1PA' s PB Ratio Range Over the Past 10 Years
Min: 0.31   Med: 1.28   Max: 8.75
Current: 0.53

During the past 13 years, Lee's Pharmaceutical Holdings's highest PB Ratio was 8.75. The lowest was 0.31. And the median was 1.28.

STU:L1PA's PB Ratio is ranked better than
92.55% of 940 companies
in the Drug Manufacturers industry
Industry Median: 1.9 vs STU:L1PA: 0.53

During the past 12 months, Lee's Pharmaceutical Holdings's average Book Value Per Share Growth Rate was -13.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -1.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -2.20% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 8.80% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Lee's Pharmaceutical Holdings was 67.30% per year. The lowest was -5.80% per year. And the median was 22.10% per year.

Back to Basics: PB Ratio


Lee's Pharmaceutical Holdings PB Ratio Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings PB Ratio Chart

Lee's Pharmaceutical Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.76 0.48 0.42 0.50

Lee's Pharmaceutical Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.41 0.42 0.38 0.50

Competitive Comparison of Lee's Pharmaceutical Holdings's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lee's Pharmaceutical Holdings's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Lee's Pharmaceutical Holdings's PB Ratio falls into.


;
;

Lee's Pharmaceutical Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Lee's Pharmaceutical Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=0.166/0.345
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Lee's Pharmaceutical Holdings  (STU:L1PA) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Lee's Pharmaceutical Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lee's Pharmaceutical Holdings Business Description

Traded in Other Exchanges
Address
Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Lee's Pharmaceutical Holdings Headlines

No Headlines